Harris (2009). „Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention”. Circulation119 (6), 902–7. o. DOI:10.1161/CIRCULATIONAHA.108.191627. PMID19171857.
(2018) „Omega‐6 fats for the primary and secondary prevention of cardiovascular disease”. Cochrane Database of Systematic Reviews11. DOI:10.1002/14651858.CD011094.pub4. PMID30488422.
(2021) „Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study”. Archives of Medical Science18 (2), 466–479. o. DOI:10.5114/aoms/136070. PMID35316920.
Garg PK, Guan W, Nomura S, Weir NL, Tintle N, Virtanen JK, Hirakawa Y, Qian F, Sun Q, Rimm E, Lemaitre RN, Jensen PN, Heckbert SR, Imamura F, Steur M, Leander K, Laguzzi F, Voortman T, Ninomiya T, Mozaffarian D, Harris WS, Siscovick DS, Tsai MY (2023). „Fatty Acids and Outcomes Research Consortium (FORCE). n-6 fatty acid biomarkers and incident atrial fibrillation: an individual participant-level pooled analysis of 11 international prospective studies.”. The American Journal of Clinical Nutrition118 (5), 921-929. o. DOI:10.1016/j.ajcnut.2023.09.008. PMID37769813.
highbeam.com
Gunstone (2007. december 1.). „Market update: Palm oil”. International News on Fats, Oils and Related Materials18 (12), 835–36. o. [2013. április 3-i dátummal az eredetiből archiválva].
nih.gov
pubmed.ncbi.nlm.nih.gov
Harris (2009). „Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention”. Circulation119 (6), 902–7. o. DOI:10.1161/CIRCULATIONAHA.108.191627. PMID19171857.
(2018) „Omega‐6 fats for the primary and secondary prevention of cardiovascular disease”. Cochrane Database of Systematic Reviews11. DOI:10.1002/14651858.CD011094.pub4. PMID30488422.
(2021) „Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study”. Archives of Medical Science18 (2), 466–479. o. DOI:10.5114/aoms/136070. PMID35316920.
Garg PK, Guan W, Nomura S, Weir NL, Tintle N, Virtanen JK, Hirakawa Y, Qian F, Sun Q, Rimm E, Lemaitre RN, Jensen PN, Heckbert SR, Imamura F, Steur M, Leander K, Laguzzi F, Voortman T, Ninomiya T, Mozaffarian D, Harris WS, Siscovick DS, Tsai MY (2023). „Fatty Acids and Outcomes Research Consortium (FORCE). n-6 fatty acid biomarkers and incident atrial fibrillation: an individual participant-level pooled analysis of 11 international prospective studies.”. The American Journal of Clinical Nutrition118 (5), 921-929. o. DOI:10.1016/j.ajcnut.2023.09.008. PMID37769813.
Gunstone (2007. december 1.). „Market update: Palm oil”. International News on Fats, Oils and Related Materials18 (12), 835–36. o. [2013. április 3-i dátummal az eredetiből archiválva].